Michael R Wilson Selected Research

Michael R Wilson Research Topics

Disease

18	COVID-19 11/2023 - 01/2020
14	Inflammation (Inflammations) 05/2024 - 06/2005
13	Encephalitis (Encephalitis, Rasmussen) 12/2023 - 06/2015
11	Lung Injury 01/2017 - 10/2003
10	Multiple Sclerosis 04/2024 - 12/2019
10	Infections 01/2024 - 01/2017
9	Pneumonia (Pneumonitis) 10/2022 - 10/2003
8	Meningitis 01/2023 - 01/2018
7	Pulmonary Edema 08/2017 - 07/2007
6	Autoimmune Diseases (Autoimmune Disease) 12/2023 - 10/2020
6	Neoplasms (Cancer) 12/2023 - 01/2019
6	Ventilator-Induced Lung Injury 01/2021 - 10/2003
5	Meningoencephalitis 01/2023 - 11/2015
4	Acute Lung Injury 03/2012 - 06/2005
3	Neuroinflammatory Diseases 01/2024 - 01/2018
3	Psychotic Disorders (Schizoaffective Disorder) 01/2023 - 01/2021
2	Blister (Bulla) 12/2023 - 04/2023
2	Autoimmune Polyendocrinopathies (Schmidt Syndrome) 12/2023 - 04/2023
2	Paraneoplastic Cerebellar Degeneration 12/2023 - 01/2021
2	Cryptococcal Meningitis 11/2023 - 01/2023
2	Neurologic Manifestations (Neurological Manifestations) 01/2023 - 01/2021
2	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 10/2022 - 03/2022
2	COVID-19 related pediatric multisystem inflammatory disease 10/2022 - 03/2022
2	Disease Progression 12/2021 - 11/2019
2	Glioma (Gliomas) 01/2020 - 01/2018
2	Autoimmune Diseases of the Nervous System 01/2019 - 06/2015
2	Orchitis 01/2019 - 01/2018
2	Fever (Fevers) 01/2019 - 01/2018
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2017 - 06/2005
2	Weight Loss (Weight Reduction) 05/2012 - 07/2010
1	Sudden Infant Death (SID) 01/2024
1	Cerebellar Diseases (Cerebellar Syndrome) 12/2023
1	Post-Acute COVID-19 Syndrome 11/2023
1	Cerebral Toxoplasmosis 11/2023
1	Lipodystrophy 04/2023
1	Cryptococcosis 01/2023
1	Onchocerciasis 01/2023
1	Urinary Tract Infections (Urinary Tract Infection) 01/2023
1	Status Epilepticus (Complex Partial Status Epilepticus) 01/2023
1	Atrophy 01/2023
1	West Nile Fever 01/2023

Drug/Important Bio-Agent (IBA)

20	Proteins (Proteins, Gene)FDA Link 12/2023 - 10/2003
16	AntibodiesIBA 11/2023 - 03/2012
15	AutoantibodiesIBA 04/2024 - 06/2015
13	CytokinesIBA 01/2024 - 10/2003
11	RNA (Ribonucleic Acid)IBA 01/2024 - 07/2016
11	AntigensIBA 11/2023 - 01/2020
9	Biomarkers (Surrogate Marker)IBA 04/2023 - 01/2018
8	Immunoglobulin G (IgG)IBA 12/2023 - 01/2019
6	AutoantigensIBA 12/2023 - 01/2020
6	LipopolysaccharidesIBA 01/2022 - 06/2005
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017 - 10/2003
5	VaccinesIBA 01/2023 - 01/2020
5	GasesIBA 08/2017 - 04/2005
4	AcidsIBA 05/2024 - 04/2013
4	2- amino- 1- methyl- 6- phenylimidazo(4,5- b)pyridineIBA 12/2023 - 03/2022
4	InterferonsIBA 11/2023 - 01/2018
4	Peptides (Polypeptides)IBA 04/2023 - 06/2015
4	COVID-19 VaccinesIBA 02/2023 - 09/2021
4	EpitopesIBA 12/2020 - 12/2019
3	Messenger RNA (mRNA)IBA 12/2023 - 01/2018
3	Intravenous Immunoglobulins (IVIG)FDA Link 01/2023 - 01/2016
3	Complement System Proteins (Complement)IBA 12/2019 - 01/2018
3	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 03/2012 - 07/2007
2	Immunoglobulin D (IgD)IBA 12/2023 - 04/2023
2	ocrelizumabIBA 01/2023 - 01/2023
2	Monoclonal AntibodiesIBA 01/2023 - 01/2021
2	SteroidsIBA 01/2022 - 01/2019
2	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2021 - 01/2019
2	Indicators and Reagents (Reagents)IBA 11/2021 - 01/2018
2	Rituximab (Mabthera)FDA Link 01/2021 - 01/2018
2	Antiviral Agents (Antivirals)IBA 01/2021 - 11/2019
2	EnzymesIBA 01/2021 - 10/2020
2	ProteomeIBA 10/2020 - 01/2019
2	DNA (Deoxyribonucleic Acid)IBA 10/2020 - 07/2011
2	Immunoglobulin M (IgM)IBA 10/2020 - 01/2018
2	Clodronic Acid (Clodronate)IBA 01/2014 - 05/2009
2	Liposomes (Liposome)IBA 01/2014 - 05/2009
2	Receptor for Advanced Glycation End ProductsIBA 04/2013 - 05/2012
2	Carbon MonoxideIBA 07/2010 - 06/2005
1	NeopterinIBA 01/2024
1	Perilipin-1IBA 04/2023
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2023
1	nitroxolineIBA 01/2023
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2023
1	QuinolonesIBA 01/2023
1	Complement Factor I (C3b Inactivator)IBA 01/2023
1	MetalsIBA 01/2023
1	chemotactic factor inactivatorIBA 01/2023

Therapy/Procedure

9	Immunotherapy 01/2023 - 10/2020
8	Therapeutics 01/2022 - 06/2005
7	Artificial Respiration (Mechanical Ventilation) 05/2024 - 10/2003
3	Critical Care (Surgical Intensive Care) 05/2024 - 08/2017
2	Aftercare (After-Treatment) 01/2023 - 01/2021
2	Transplantation 01/2023 - 10/2018
2	Length of Stay 01/2020 - 01/2007
1	Organ Transplantation 01/2023
1	Blood Transfusion (Blood Transfusions) 01/2023
1	Kidney Transplantation 01/2023
1	Art Therapy 01/2023